Fumio Endo

442 total citations
10 papers, 288 citations indexed

About

Fumio Endo is a scholar working on Molecular Biology, Clinical Biochemistry and Immunology and Allergy. According to data from OpenAlex, Fumio Endo has authored 10 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Clinical Biochemistry and 3 papers in Immunology and Allergy. Recurrent topics in Fumio Endo's work include Metabolism and Genetic Disorders (3 papers), Cell Adhesion Molecules Research (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Fumio Endo is often cited by papers focused on Metabolism and Genetic Disorders (3 papers), Cell Adhesion Molecules Research (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). Fumio Endo collaborates with scholars based in Japan and Canada. Fumio Endo's co-authors include D.W. Cox, Koji Inui, Manoj Nanji, Takashi Nakajima, Hiroshi Mitsubuchi, Kohji Ohta, Yasuhiro Indo, Ichiro Matsuda, Ichiro Matsuda and Takaya Tohma and has published in prestigious journals such as Kidney International, The American Journal of Human Genetics and Gene.

In The Last Decade

Fumio Endo

10 papers receiving 273 citations

Peers

Fumio Endo
Comparison fields: 5 of 61
  • Nutrition and Dietetics 106
  • Molecular Biology 95
  • Health, Toxicology and Mutagenesis 85
  • Hematology 58
  • Genetics 54
Replace Il‐Ha Lee with:
Il‐Ha Lee Australia
Ichiro Matsuda Japan
Agnieszka Styś Poland
Miranda Durkie United Kingdom
Fatma Al‐Jasmi United Arab Emirates
AW Norman United States
Zhengqing Qiu China
Fernanda R.O. Calderon United States
J. M�ller-H�cker Germany
Vahe Mokini Albania
Il‐Ha Lee Australia View profile →
Citations per field, relative to Fumio Endo
Fumio Endo · 1×
Citations per year, relative to Fumio Endo
Fumio Endo · 1×

Countries citing papers authored by Fumio Endo

Since Specialization
Citations

This map shows the geographic impact of Fumio Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumio Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumio Endo more than expected).

Fields of papers citing papers by Fumio Endo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumio Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumio Endo. The network helps show where Fumio Endo may publish in the future.

Co-authorship network of co-authors of Fumio Endo

This figure shows the co-authorship network connecting the top 25 collaborators of Fumio Endo. A scholar is included among the top collaborators of Fumio Endo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumio Endo. Fumio Endo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
# Work Indexed citations
1 49
2 19
3 8
4 109
5 21
6 5
7 16
8 9
9 14
10 38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026